Search results

Filter (5 in use)

Type

  • Filter by Guidance (1)

Status 2 selected

  • Filter by Published (81)
  • Filter by In development (33)
  • Filter by Awaiting development (7)
  • Filter by Discontinued (2)
  • Filter by Topic selection (2)
  • Remove filter for In consultation (1)
  • Remove filter for Proposed (0)

Last updated

  • Filter by Last 3 months (0)
  • Filter by Last 6 months (0)
  • Filter by Last year (0)
  • Filter by Last 3 years (0)

Guidance programme 3 selected

  • Filter by Interventional procedures guidance (4)
  • Filter by NICE guidelines (3)
  • Remove filter for Highly specialised technologies guidance (1)
  • Filter by Technology appraisal guidance (1)
  • Remove filter for Antimicrobial prescribing guidelines (0)
  • Remove filter for Diagnostics guidance (0)

1 result

Sorted by Relevance . | Sort by Date

  • In consultation Remove In consultation filter
  • Proposed Remove Proposed filter
  • Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
  • Antimicrobial prescribing guidelines Remove Antimicrobial prescribing guidelines filter
  • Diagnostics guidance Remove Diagnostics guidance filter
  1. Velmanase alfa for treating alpha-mannosidosis [ID800]: evaluation consultation

    We are listening to your views on this Highly specialised technology. Comments close 16 August 2022.

    Type
    Highly specialised technologies guidance
    Status
    In consultation